TITLE

SFDA GRANTS MIRACLE LASER APPROVAL TO SELL SYNERON PRODUCTS

PUB. DATE
July 2005
SOURCE
Worldwide Biotech;Jul2005, Vol. 17 Issue 7, p7
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the approval to Miracle Laser, the Chinese distributor of Syneron Medical Ltd., by the State Food & Drug Administration of China, to sell Syneron's products in the country, as of July 2005. Advantages of the approval to Syneron's performance in the medical laser device market; Details of the approval; Background information on Miracle Laser.
ACCESSION #
17706736

 

Related Articles

  • PRETTY FIT.  // Women's Fitness;Feb2014, Issue 123, p101 

    The article discusses the results of research conducted by medical aesthetics firm Syneron Medical Ltd. that 57 percent of women do full face makeup for marathon day and states that 72 percent of women wear makeup to the gym.

  • China clears GeneChip for in vitro diagnostic use.  // Medical Device Daily;2/21/2012, Vol. 16 Issue 34, p8 

    The article reports an the approval granted by China's State Food and Drug Administration for the use of Affymetrix's GeneChip system 3000Dx v.2 in in vitro diagnosis.

  • SFDA approves Alex TriVantage.  // Medical Device Daily;2/16/2010, Vol. 14 Issue 30, p9 

    The article reports on the approval granted by the State Food and Drug Administration to Candela for its Alex TriVantage multi-wavelength, Q-switched laser system and the GentleMax multiple wavelength workstation for sale throughout China.

  • SFDA Cancelled Thousands of Drug Approval Documents.  // China Chemical Reporter;3/21/2010, Vol. 21 Issue 6, p17 

    The article reports that China's State Food and Drug Administration (SFDA) has cancelled around 4300 items of drug approval documents in 2009 after checking the existing 170 000 items.

  • NEW ADDITION TO VELA PLATFORM REDUCES THIGH CIRCUMFERENCE, CELLULITE WITH FEWER TREATMENTS.  // Cosmetic Surgery Times;Oct2007, Vol. 10 Issue 9, p50 

    The article evaluates the Velashape, the newest addition to the Vela platform noninvasive device from Syneron Medical Ltd.

  • Elure Dazzles Dermatologists. Lewis, Wendy // Plastic Surgery Practice;Dec2012, Vol. 22 Issue 12, pS-1 

    The article evaluates the Elure, a non irritating formulation from Syneron Medical Ltd. which regulated melanin production in the skin and is an alternative to hydroquinone.

  • The Tucson INSIDER.  // Inside Tucson Business;3/1/2013, Vol. 22 Issue 40, p5 

    The article reports on the visit of the representatives from Chinese State Food and Drug Administration at the University of Arizona College of Pharmacy and Critical Path Institute (C-Path) in February 2013, and on the impact of Tucson International Airport in the tourism in Tucson, Arizona.

  • China announces updates for monitoring of adverse events. McCARTY, MARK // Medical Device Daily;1/22/2009, Vol. 13 Issue 13, p2 

    The article reports on the announcement by China's State Food and Drug Administration (SFDA) on its web site that it has upgraded its requirements for monitoring adverse events related to medical devices. The move is seen as part of a broader push by the agency to upgrade its regulatory...

  • Clinic Roundup.  // BioWorld Today;12/29/2010, Vol. 21 Issue 250, p5 

    The article reports that the China State Food and Drug Administration has approved an application by Sinovac Biotech Ltd. to commence clinical trials for its inactivated EV71 vaccine against hand, foot and mouth disease.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics